In a shift away from next-generation Covid-19 vaccines, the Trump administration is investing $500 million in a vaccine ...

China restated its case that Covid-19 may have originated in the United States in a white paper on its pandemic response ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

China is blaming the United States for the origin of COVID-19, accusing Washington of "evading responsibility" for the virus ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The Chinese accusations come after the White House revamped its COVID-19 information earlier this month to push out the assertion that COVID-19 leaked out of a lab in the Wuhan Institute of ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

BEIJING (Reuters) -China released a white paper on COVID-19 prevention, control and origins tracing on Wednesday, the ...

Kennedy has focused his healthcare crusade on his contention that American healthcare prioritizes treating chronic illnesses ...

Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...

Americans’ confidence in the economy slumped for the fifth straight month to the lowest level since the onset of COIVD-19.